2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Rodríguez-Carrio, J., Burska, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (14 more authors) (2023) 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the Rheumatic Diseases, 82 (6). pp. 754-762. ISSN 0003-4967

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

This item is protected by copyright. This is an author produced version of an article published in the Annals of the Rheumatic Diseases (ARD). Uploaded in accordance with the publisher's self-archiving policy.

Dates:
  • Published: June 2023
  • Published (online): 1 March 2023
  • Accepted: 4 February 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 04 Dec 2024 10:09
Last Modified: 06 Dec 2024 13:25
Status: Published
Publisher: BMJ Publishing Group
Identification Number: 10.1136/ard-2022-223628
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics